Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts. - Wikidata - awgldk - TriplyDB

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

http://www.wikidata.org/entity/Q33893647

about

Aptamers: A promising chemical antibody for cancer therapy Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity Nucleic acid aptamers: research tools in disease diagnostics and therapeutics Beyond DNA repair: DNA-PK function in cancer Oligonucleotide Therapies: The Past and the Present Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer Smart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapy Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer.A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment Aptamer-Drug Conjugates Screening and Identifying a Novel ssDNA Aptamer against Alpha-fetoprotein Using CE-SELEX.Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.GCPII imaging and cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.Nucleic acid aptamers: clinical applications and promising new horizons Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.CD4 aptamer-RORγt shRNA chimera inhibits IL-17 synthesis by human CD4(+) T cells.Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Cell-internalization SELEX: method for identifying cell-internalizing RNA aptamers for delivering siRNAs to target cells Targeted inhibition of prostate cancer metastases with an RNA aptamer to prostate-specific membrane antigen.A cell-based high-throughput screening assay for radiation susceptibility using automated cell counting Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment Recent progress in targeting cancer.Cell-penetrating RNAs: new keys to the castle.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticles An RNA alternative to human transferrin: a new tool for targeting human cells.Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts Current progress of RNA aptamer-based therapeutics.A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity.Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.In vivo gene delivery by nonviral vectors: overcoming hurdles?Application of aptamers for targeted therapeutics.PET imaging in prostate cancer: focus on prostate-specific membrane antigen Ex vivo culture of human prostate tissue and drug development.

P2860

Q26766832-C349EEE7-5568-411D-A873-857897EA1E0D Q26782201-CA1B2BFB-F18C-4F65-843D-6908D0BA1BC4 Q26824321-AE5EAD5E-8833-4AA0-BC6E-4F5F237FAE5D Q26827232-DE3A6F17-3924-4F60-A821-E88719CD1BCE Q27002403-3CB35269-02B5-437A-A1A7-873FA3944548 Q27007505-BDBEB610-9982-4FA5-9CB6-5E237FCF74A2 Q27025832-57AC96A0-5CE3-4BB2-A96B-684204DF113E Q27346788-AD04E0B8-30B3-4577-9C97-6385BF369098 Q28260029-BE1A5EB8-35B5-449B-9FC9-09570303DB2A Q28274124-DAACC97A-CF8B-45AE-8CE4-BF7758A53D01 Q28468281-4B4C6A35-DA70-4E9C-A338-F35198C5533E Q30670593-A14C526C-4693-43E6-8C8E-1BF8F98D6EA2 Q33724277-2E201D32-E8EA-4C74-8B76-A0FD6B2F4E4E Q33827632-3854A16F-597F-4A16-8F3A-C5B8A2A23695 Q33834772-9F9E8AD7-FAA7-4B15-94C7-FE620C77B950 Q33887448-D8F6836C-8AFB-4955-A6EB-73A1F769F2F4 Q34028112-99C8D259-C564-4C82-9EAA-2DB29C03FB71 Q34152258-C52B4451-0577-422B-A309-46372D902793 Q34435503-5A63E1ED-C4D3-4C3B-99CA-483A1BA1EEB1 Q34698624-37BFFAAA-0D67-4112-88E8-A13438364AE0 Q35335653-5A25029E-29BC-4A00-AB04-FB82E90C6FDB Q35600421-829463F2-CFEB-4356-A8D7-391C58697E0A Q35608501-C4819EAC-E5C7-430D-BE8A-66F3681E6D35 Q35640737-050E3AA9-93D3-4327-A83D-EEB63FB03ED6 Q35740782-5BBAED2B-FE37-48F5-92F2-CABE137A552E Q35749991-FE52F0B9-8D52-4595-B43F-8EF2EBD2529D Q35846835-37B35CC2-1E46-4949-B11D-64E6489BD16B Q36077849-EA834406-02DC-4BE8-88E9-AC5AECC6F434 Q36107033-0C751357-5F1C-49C5-AB7E-A02DD265522C Q36359552-C2FBDB57-ABBD-421F-88F7-17565E398FAC Q36365202-5B91DABB-CF0C-41BC-AAF0-91ECFB7E9395 Q36939199-5B6FDB99-6DEB-43CE-95D3-40D5130E1E69 Q37065549-2A61FCF2-2B5C-4DF7-B0E7-C7EAD511C50B Q37092020-7B3C495F-6374-4C96-A7D5-928A80973A77 Q37410596-80FFE8D3-560E-4355-8C47-09481A93862A Q37696045-0FC7E12D-F98B-41A2-BD5D-21987B80D77B Q38004708-1C0009A5-DC27-43A7-807E-013D1B1BE94B Q38096870-565776B0-1699-4B0B-8B8C-44B2025311B5 Q38099369-EAD68E13-9CBC-4A40-AB2F-4CC3BFA47FEA Q38113460-AD199A43-BFD8-4942-8F9F-DA27DDD84074

P2860

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

http://www.wikidata.org/entity/Q33893647

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@ast

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@en

type

label

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@ast

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@en

prefLabel

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@ast

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@en

P1433

Q33893647-0051D42C-5563-4238-99C2-447BBA95D7F4

P1476

Q33893647-CA5C7431-5826-4576-96EC-F8A696ADF1BC

P2093

Q33893647-3F8EB831-2C4C-4D50-AAB2-52DA200A8CFF

Q33893647-981E0593-B08C-400A-BA17-7000BFF3CA65

Q33893647-9A948959-9FD4-4348-8754-ACB297C78D78

Q33893647-9C816028-EF4B-423F-9AFB-549013D270A2

Q33893647-A4969149-1794-4166-BDE8-6F3F6C5CBC7E

Q33893647-E7A86DE4-54A3-4FB8-825B-CBC08AFA7E70

Q33893647-F6F9FBD5-703D-4294-B9E0-36F7D75F0F9B

Q33893647-F706E59F-6F6C-4175-88AD-2B732CAB80D9

P2860

Q33893647-04C51697-BC11-46B4-93BC-EBD99E520BEB

Q33893647-0513D861-B459-4EB4-92A8-86257F933D7F

Q33893647-06D61E04-A822-47A2-8D01-AF33D3030A63

Q33893647-08263865-1AB9-4BDD-827D-3A76D1574ED9

Q33893647-14080403-F55F-474E-A3AB-63DE15B9A408

Q33893647-14B29C02-1704-435B-AE6D-365B32C93AA9

Q33893647-14E91A70-247F-4EC0-BF39-A43D142752C0

Q33893647-1685E7F2-8CFA-46BD-97CB-416F346E0B0E

Q33893647-2B8CB0B6-39B2-49ED-994C-11060B3673A5

Q33893647-3159BAC2-0D81-45E4-B5D4-AC1390B5B645

P304

Q33893647-42FE07B8-9A27-4C15-82DB-4B60F1C71300

P31

Q33893647-44638C3A-9D16-4361-8740-C75805100EB5

P356

Q33893647-E4C429EF-7439-4E41-B462-CB8BF744DF0C

P407

Q33893647-33E31A9E-DC9C-4B15-ACFE-550B80256B98

P433

Q33893647-EF900F37-E94F-4580-961A-4EE2143DDB38

P478

Q33893647-E764985E-5A5E-49C5-B695-7AC7282C08B3

P50

Q33893647-E4A0EF63-309A-4CB6-8AF8-BD2493FDC214

P577

Q33893647-2365491C-0E24-4135-9DF6-920C7556DAB5

P5875

Q33893647-8C86C6A7-6A81-46B6-B6B9-5970D87049BB

P698

Q33893647-B1B3E39C-9893-4E72-BFF5-6064504FD5F7

P921

Q33893647-15AD3443-0669-4579-8F9A-A826EE032490

P932

Q33893647-7E5BE68A-62DF-4C67-9CB2-B3449B6D9FEB

P356

P1433

Journal of Clinical Investigation

P1476

Prostate-targeted radiosensiti ...... ras in human tumor xenografts.

@en

P2093

Judit Ribas

http://www.w3.org/2001/XMLSchema#string

Marikki Laiho

http://www.w3.org/2001/XMLSchema#string

Mark Castanares

http://www.w3.org/2001/XMLSchema#string

Shawn E Lupold

http://www.w3.org/2001/XMLSchema#string

Theodore L DeWeese

http://www.w3.org/2001/XMLSchema#string

Xiaohua Ni

http://www.w3.org/2001/XMLSchema#string

Yonggang Zhang

http://www.w3.org/2001/XMLSchema#string

Zhewei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

A general framework for quantifying the effects of DNA repair inhibitors on radiation sensitivity as a function of dose

Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer

The promises and pitfalls of RNA-interference-based therapeutics

Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Genome maintenance mechanisms for preventing cancer

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

Chromosomal stability and the DNA double-stranded break connection

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

DNA double-strand break repair: from mechanistic understanding to cancer treatment

The DNA-dependent protein kinase

P304

2383-2390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45109

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Wasim H. Chowdhury

P577

2011-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51111045

http://www.w3.org/2001/XMLSchema#string

P698

21555850

http://www.w3.org/2001/XMLSchema#string

P921

P932

3104752

http://www.w3.org/2001/XMLSchema#string